共 8 条
[1]
[4]
Prevention of Hepatitis B Recurrence after Liver Transplantation.[J].Daniel Seehofer;Thomas Berg.Transplantation.2005, 1S S
[5]
Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus.[J]..Transplantation Proceedings.2005, 9
[6]
Interferon Combined With Cyclosporine Treatment as an Effective Countermeasure Against Hepatitis C Virus Recurrence in Liver Transplant Patients With End-Stage Hepatitis C Virus Related Disease.[J].K. Inoue;M. Yoshiba.Transplantation Proceedings.2005, 2
[7]
Double-Blind Comparison of Hepatitis C Histological Recurrence Rate in HCV+ Liver Transplant Recipients Given Basiliximab+Steroids or Basiliximab+Placebo; in addition to Cyclosporine and Azathioprine.[J].Franco Filipponi;Francesco Callea;Mauro Salizzoni;Gian Luca Grazi;Luigi Rainero Fassati;Massimo Rossi;Andrea Risaliti;Patrizia Burra;Salvatore Agnes;Luciano De Carlis;Umberto Valente;Roberto Ferrara;Roberto Pisati.Transplantation.2004, 10
[8]
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients.[J].Eugene R. Schiff;Ching-Lung Lai;Stefanos Hadziyannis;Peter Neuhaus;Norah Terrault;Massimo Colombo;Hans L. Tillmann;Didier Samuel;Stefan Zeuzem;Leslie Lilly;Maria Rendina;Jean-Pierre Villeneuve;Nicole Lama;Craig James;Michael S. Wulfsohn;Hamid Namini;Christopher Westland;Shelly Xiong;Gavin S. Choy;Sally Van Doren;John Fry;Carol L. Brosgart.Hepatology.2003, 6

